IJCS | Volume 32, Nº1, January/ February 2019

69 46. Steingrub JS, Celoria G, Vickers-Lahti M, Teres D, Bria W. Therapeutic impact of pulmonary artery catheterization in a medical/surgical ICU. Chest. 1991;99(6):1451-5. 47. Aoka Y, Hagiwara N, Kasanuki H. Heterogeneity of hemodynamic parameters in untreated primary hypertension, and individualization of antihypertensive therapy based on noninvasive hemodynamic measurements. Clin Exp Hypertens. 2013;35(1):61-6. 48. Nazario Leao R, Marques da Silva P. Diastolic dysfunction in hypertension. Hipertens Riesgo Vasc. 2017;34(3):128-39. 49. McFetridge-Durdle JA, Routledge FS, Parry MJ, Dean CR, Tucker B. Ambulatory impedance cardiography in hypertension: a validation study. Eur J Cardiovasc Nurs. 2008;7(3):204-13. 50. Gardner SF, Schneider EF. 24-Hour ambulatory blood pressure monitoring in primary care. J Am Board Fam Pract. 2001;14(3):166-71. 51. Sherwood A, McFetridge J, Hutcheson JS. Ambulatory impedance cardiography: a feasibility study. J Appl Physiol (1985). 1998;85(6):2365-9. 52. Barnes VA, JohnsonMH, Treiber FA. Temporal stability of twenty-four- hour ambulatory hemodynamic bioimpedance measures in African American adolescents. Blood Press Monit. 2004;9(4):173-7. 53. Licht CM, de Geus EJ, Penninx BW. Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab. 2013;98(6):2484-93. 54. Sramek BB TJ, Hojerov M, Cervenka V. Normohemodynamic goal -oriented antihypertensive therapy improves the outcome. [abstract]. In: 11 th Scientific Meeting, New York (NY), 1996. Am J Hypertens. 1996;9:141A. 55. Sharman DL, Gomes CP, Rutherford JP. Improvement in blood pressure control with impedance cardiography-guided pharmacologic decision making. Congest Heart Fail. 2004;10(1):54-8. 56. Krzesinski P, Gielerak G, Kowal J, Piotrowicz K. Usefulness of impedance cardiography in optimisation of antihypertensive treatment in patients withmetabolic syndrome: a randomised prospective clinical trial. Kardiol Pol. 2012;70(6):599-607. 57. Krzesinski P, Gielerak GG, Kowal JJ. A "patient-tailored" treatment of hypertension with use of impedance cardiography: a randomized, prospective and controlled trial. Med Sci Monit. 2013 Apr 5;19:242-50. 58. Krzesinski P, Gielerak G, Stanczyk A, Piotrowicz K, Skrobowski A. Who benefits more fromhemodynamically guided hypotensive therapy? The experience from two randomized, prospective and controlled trials. Ther Adv Cardiovasc Dis. 2016;10(1):21-9. 59. Krzesinski P, Gielerak G, Stanczyk A, Piotrowicz K, Uzi ę bło- Ż yczkowska B, Banak M, et al. The effect of hemodynamically- guided hypotensive therapy in one-year observation: randomized, prospective and controlled trial (FINEPATH study). Cardiol J. 2016;23(2):132-40. Leão and Silva Impedance cardiography and hypertension Int J Cardiovasc Sci. 2019;32(1)61-69 Review Article This is an open-access article distributed under the terms of the Creative Commons Attribution License